| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93bb978c9fe97c06684421435a0f7559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_457a7761bb0b0ae89f3bf95bbc5d08a6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1996-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8482476f08370e554294b0b9695ff521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc27281530ac68105f3e210842a00a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63374ef7e005b60ca9edf26778ae8549 |
| publicationDate |
1996-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9621403-A1 |
| titleOfInvention |
Dietary phytoestrogen in estrogen replacement therapy |
| abstract |
Disclosed is a pharmaceutical composition for oral delivery. The composition includes about 1-2 mg mammalian estrogen and about 25-100 mg phytoestrogen. Compositions of the type described above are utilized, for example, in a therapeutic regimen designed to reduce the risk of coronary heart disease and osteoporosis in postmenopausal women. This method comprises the oral administration of a composition comprising a mixture of estrogen and phytoestrogen, the dosages of mammalian estrogen and phytoestrogen being about 1-2 mg, about 25-100 mg, respectively. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0170212-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0016759-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0170212-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009102342-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0016759-A2 |
| priorityDate |
1995-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |